Ceritinib (INN, trade name Zykadia ) is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April 2014.
via PubMed
{{Infobox drug | image = Ceritinib structure.svg | image_class = skin-invert-image | width = 275 | alt = | caption =
| pronounce = | tradename = Zykadia, others | Drugs.com = | MedlinePlus = a614027 | DailyMedID = Ceritinib | pregnancy_AU = | pregnancy_category = | routes_of_administration = By mouth | ATC_prefix = L01 | ATC_suffix = ED02
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).